Search

everythinglearnresearchcommunity

for

Search:↓

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

The document concludes that scalp conditions have various causes and can present in many different ways.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Tofacitinib is an effective and safe treatment for alopecia areata.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Phototherapy can help treat hair loss in alopecia areata.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.